{"id":"https://openalex.org/W7170177179","doi":"https://doi.org/10.1016/s1474-4422(26)00214-0","title":"Tolerability, safety, and efficacy of atogepant versus topiramate in adults with migraine (TEMPLE): a randomised, head-to-head, phase 3b trial","display_name":"Tolerability, safety, and efficacy of atogepant versus topiramate in adults with migraine (TEMPLE): a randomised, head-to-head, phase 3b trial","publication_year":2026,"publication_date":"2026-07-01","ids":{"openalex":"https://openalex.org/W7170177179","doi":"https://doi.org/10.1016/s1474-4422(26)00214-0","pmid":"https://pubmed.ncbi.nlm.nih.gov/42492556"},"language":"en","primary_location":{"id":"doi:10.1016/s1474-4422(26)00214-0","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s1474-4422(26)00214-0","pdf_url":null,"source":{"id":"https://openalex.org/S70053155","display_name":"The Lancet Neurology","issn_l":"1474-4422","issn":["1474-4422","1474-4465"],"is_oa":false,"is_in_doaj":false,"is_core":true,"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Lancet Neurology","raw_type":"journal-article"},"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1016/s1474-4422(26)00214-0","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5051082265","display_name":"Uwe Reuter","orcid":"https://orcid.org/0000-0002-8527-0725"},"institutions":[{"id":"https://openalex.org/I7877124","display_name":"Charit\u00e9 - Universit\u00e4tsmedizin Berlin","ror":"https://ror.org/001w7jn25","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I7877124"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Uwe Reuter","raw_affiliation_strings":["Charit\u00e9 Universit\u00e4tsmedizin Berlin, Berlin, Germany; University Hospital Bonn, Bonn, Germany. Electronic address: uwe.reuter@charite.de"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Charit\u00e9 Universit\u00e4tsmedizin Berlin, Berlin, Germany; University Hospital Bonn, Bonn, Germany. Electronic address: uwe.reuter@charite.de","institution_ids":["https://openalex.org/I7877124"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082974712","display_name":"Annelies Van Dycke","orcid":null},"institutions":[{"id":"https://openalex.org/I4210123377","display_name":"AZ Sint-Jan","ror":"https://ror.org/030h1vb90","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I4210123377"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Annelies Van Dycke","raw_affiliation_strings":["Department of Neurology, General Hospital Sint-Jan Bruges, Brugge, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, General Hospital Sint-Jan Bruges, Brugge, Belgium","institution_ids":["https://openalex.org/I4210123377"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5135733411","display_name":"Jan Versijpt","orcid":null},"institutions":[{"id":"https://openalex.org/I4210126764","display_name":"Universitair Ziekenhuis Brussel","ror":"https://ror.org/038f7y939","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I4210126764"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Jan Versijpt","raw_affiliation_strings":["Department of Neurology, Universitair Ziekenhuis Brussel, Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, Universitair Ziekenhuis Brussel, Brussels, Belgium","institution_ids":["https://openalex.org/I4210126764"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063750372","display_name":"Dagny Holle","orcid":"https://orcid.org/0000-0003-4872-0384"},"institutions":[{"id":"https://openalex.org/I4210161917","display_name":"West German Heart and Vascular Center Essen","ror":"https://ror.org/05aw6p704","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210119759","https://openalex.org/I4210161917"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Dagny Holle-Lee","raw_affiliation_strings":["Department of Neurology, West German Headache and Vertigo Center Essen, University of Essen, Essen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, West German Headache and Vertigo Center Essen, University of Essen, Essen, Germany","institution_ids":["https://openalex.org/I4210161917"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039769970","display_name":"Mark Kristof Farkas","orcid":"https://orcid.org/0000-0002-6016-2883"},"institutions":[{"id":"https://openalex.org/I101202996","display_name":"Semmelweis University","ror":"https://ror.org/01g9ty582","country_code":"HU","type":"education","lineage":["https://openalex.org/I101202996"]}],"countries":["HU"],"is_corresponding":false,"raw_author_name":"Mark Kristof Farkas","raw_affiliation_strings":["Pediatric Center, Semmelweis University, Budapest, Hungary"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pediatric Center, Semmelweis University, Budapest, Hungary","institution_ids":["https://openalex.org/I101202996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064341657","display_name":"Stewart J. Tepper","orcid":"https://orcid.org/0000-0002-9879-6638"},"institutions":[{"id":"https://openalex.org/I4210137678","display_name":"New England Institute for Neurology and Headache","ror":"https://ror.org/04a2ksf56","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137678"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stewart J Tepper","raw_affiliation_strings":["New England Institute for Neurology and Headache, Stamford, CT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"New England Institute for Neurology and Headache, Stamford, CT, USA","institution_ids":["https://openalex.org/I4210137678"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030522092","display_name":"Giovanna Forero","orcid":null},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Giovanna Forero","raw_affiliation_strings":["AbbVie, North Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbbVie, North Chicago, IL, USA","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5143533483","display_name":"Lei Luo","orcid":null},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lei Luo","raw_affiliation_strings":["AbbVie, North Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbbVie, North Chicago, IL, USA","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5143522700","display_name":"Hua Guo","orcid":null},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hua Guo","raw_affiliation_strings":["AbbVie, North Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbbVie, North Chicago, IL, USA","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5143500427","display_name":"Eric Cohen","orcid":null},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric Cohen","raw_affiliation_strings":["AbbVie, North Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbbVie, North Chicago, IL, USA","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019116734","display_name":"Brett Dabruzzo","orcid":"https://orcid.org/0009-0008-3048-2633"},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brett Dabruzzo","raw_affiliation_strings":["AbbVie, North Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbbVie, North Chicago, IL, USA","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5138346639","display_name":"Pranav Gandhi","orcid":null},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pranav Gandhi","raw_affiliation_strings":["AbbVie, North Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbbVie, North Chicago, IL, USA","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5044533873","display_name":"Kriszti\u00e1n Nagy","orcid":"https://orcid.org/0000-0002-6935-0995"},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Krisztian Nagy","raw_affiliation_strings":["AbbVie, North Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbbVie, North Chicago, IL, USA","institution_ids":["https://openalex.org/I2948539688"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5051082265"],"corresponding_institution_ids":["https://openalex.org/I7877124"],"apc_list":{"value":6300,"currency":"USD","value_usd":6300},"apc_paid":{"value":6300,"currency":"USD","value_usd":6300},"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.91512245,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10498","display_name":"Migraine and Headache Studies","score":0.987500011920929,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10498","display_name":"Migraine and Headache Studies","score":0.987500011920929,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12464","display_name":"Neurological Complications and Syndromes","score":0.0027000000700354576,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10416","display_name":"Traumatic Brain Injury Research","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/migraine","display_name":"Migraine","score":0.7031999826431274},{"id":"https://openalex.org/keywords/topiramate","display_name":"Topiramate","score":0.6662999987602234},{"id":"https://openalex.org/keywords/clinical-trial","display_name":"Clinical trial","score":0.3630000054836273},{"id":"https://openalex.org/keywords/phase","display_name":"Phase (matter)","score":0.33059999346733093},{"id":"https://openalex.org/keywords/discontinuation","display_name":"Discontinuation","score":0.2757999897003174},{"id":"https://openalex.org/keywords/phases-of-clinical-research","display_name":"Phases of clinical research","score":0.26809999346733093}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8427000045776367},{"id":"https://openalex.org/C2778541695","wikidata":"https://www.wikidata.org/wiki/Q133823","display_name":"Migraine","level":2,"score":0.7031999826431274},{"id":"https://openalex.org/C2777683783","wikidata":"https://www.wikidata.org/wiki/Q221174","display_name":"Topiramate","level":3,"score":0.6662999987602234},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5156999826431274},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3630000054836273},{"id":"https://openalex.org/C44280652","wikidata":"https://www.wikidata.org/wiki/Q104837","display_name":"Phase (matter)","level":2,"score":0.33059999346733093},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.2757999897003174},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.27059999108314514},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.26809999346733093},{"id":"https://openalex.org/C2777172819","wikidata":"https://www.wikidata.org/wiki/Q240642","display_name":"Valproic Acid","level":3,"score":0.2632000148296356},{"id":"https://openalex.org/C2911171718","wikidata":"https://www.wikidata.org/wiki/Q133823","display_name":"Migraine Disorders","level":3,"score":0.2632000148296356},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.251800000667572}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1016/s1474-4422(26)00214-0","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s1474-4422(26)00214-0","pdf_url":null,"source":{"id":"https://openalex.org/S70053155","display_name":"The Lancet Neurology","issn_l":"1474-4422","issn":["1474-4422","1474-4465"],"is_oa":false,"is_in_doaj":false,"is_core":true,"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Lancet Neurology","raw_type":"journal-article"},{"id":"pmid:42492556","is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42492556","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Lancet. Neurology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1016/s1474-4422(26)00214-0","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s1474-4422(26)00214-0","pdf_url":null,"source":{"id":"https://openalex.org/S70053155","display_name":"The Lancet Neurology","issn_l":"1474-4422","issn":["1474-4422","1474-4465"],"is_oa":false,"is_in_doaj":false,"is_core":true,"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Lancet Neurology","raw_type":"journal-article"},"sustainable_development_goals":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320309117","display_name":"AbbVie","ror":"https://ror.org/02g5p4n58"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":28,"referenced_works":["https://openalex.org/W1459330387","https://openalex.org/W1951293016","https://openalex.org/W2005239637","https://openalex.org/W2549116677","https://openalex.org/W2977140154","https://openalex.org/W2991026268","https://openalex.org/W3084814300","https://openalex.org/W3107747907","https://openalex.org/W3173551259","https://openalex.org/W3193766373","https://openalex.org/W3212380527","https://openalex.org/W4210696369","https://openalex.org/W4282934967","https://openalex.org/W4309263777","https://openalex.org/W4385306988","https://openalex.org/W4390150435","https://openalex.org/W4391770845","https://openalex.org/W4392644833","https://openalex.org/W4393150796","https://openalex.org/W4396663972","https://openalex.org/W4400030349","https://openalex.org/W4403602902","https://openalex.org/W4405200530","https://openalex.org/W4405712042","https://openalex.org/W4411609962","https://openalex.org/W4414011969","https://openalex.org/W4414542645","https://openalex.org/W4415554439"],"related_works":[],"abstract_inverted_index":{"BACKGROUND:":[0],"Oral":[1],"calcitonin":[2],"gene-related":[3],"peptide":[4],"(CGRP)":[5],"receptor":[6],"antagonists":[7],"such":[8],"as":[9,569],"atogepant":[10,62,164,389,427,447,463,488,524,566],"have":[11,20],"been":[12,22],"approved":[13],"for":[14,41,604],"preventive":[15,29,39,573,602],"treatment":[16,40,77,93,99,193,217,307,538],"of":[17,61,132,174,214,265,273,285,294,303,393,402,422,432,492,501],"migraine":[18,42,110,133,138,239,248,484,518,572],"but":[19,43],"not":[21],"compared":[23,395,494,559],"directly":[24],"with":[25,67,89,104,315,396,495,560],"conventional":[26,36],"oral":[27,37,571],"non-specific":[28],"treatments.":[30],"Topiramate":[31],"is":[32,46,313,327,333],"a":[33,82,90,96,130],"widely":[34],"used":[35],"non-migraine-specific":[38],"its":[44],"use":[45],"often":[47],"limited":[48],"by":[49,191,419],"poor":[50],"tolerability.":[51],"We":[52],"aimed":[53],"to":[54,69,74,163,196,226,299,376,411,468,508,542,584],"evaluate":[55],"the":[56,126,145,152,201,205,215,219,254,324,330,367,381,388,397,426,435,462,487,496,523,533,599],"tolerability,":[57],"safety,":[58],"and":[59,95,108,125,134,150,155,241,276,318,329,340,352,357,429,448,511,554,565],"efficacy":[60,223,228,555],"versus":[63],"topiramate":[64,170,372,398,436,497,534,564],"in":[65,102,106,204,236,245,253,366,387,425,434,443,449,461,481,486,515,522,577,597],"adults":[66],"migraine,":[68],"provide":[70,589],"direct":[71,590],"comparative":[72,591],"evidence":[73,592],"help":[75],"inform":[76],"selection.":[78],"METHODS:":[79],"TEMPLE":[80,312],"was":[81,385,465,520],"phase":[83],"3b,":[84],"randomised,":[85],"double-dummy,":[86],"active-controlled":[87],"trial":[88],"24-week":[91,382],"double-blind":[92,202,220,325,383],"period":[94,203,272,284,326,332,384],"52-week":[97],"open-label":[98,331],"period,":[100],"done":[101],"sites":[103],"experience":[105],"diagnosing":[107],"treating":[109],"across":[111,144,380,556],"12":[112],"countries":[113],"(Austria,":[114],"Belgium,":[115],"Canada,":[116],"Czechia,":[117],"France,":[118],"Germany,":[119],"Hungary,":[120],"Israel,":[121],"Italy,":[122],"Poland,":[123],"Portugal,":[124],"UK).":[127],"Participants":[128,158],"had":[129,268,277],"history":[131],"at":[135,230,477],"least":[136,231,478],"4":[137],"days":[139,240,249,485,519],"per":[140],"month":[141,300],"on":[142,305,446,452,581],"average":[143],"3":[146],"months":[147,251],"before":[148],"screening":[149,154],"during":[151,200,218,250],"combined":[153],"baseline":[156,235,244,271,514],"period.":[157],"were":[159,229,346,349,364,417],"randomly":[160,350],"assigned":[161],"1:1":[162],"(60":[165],"mg":[166,548],"once":[167,549],"daily)":[168],"or":[169,179,308],"(highest":[171],"tolerated":[172],"dose":[173,213,264,293],"50":[175],"mg/day,":[176,178],"75":[177],"100":[180],"mg/day)":[181],"using":[182],"interactive":[183],"response":[184],"technology.":[185],"The":[186],"primary":[187],"endpoint":[188],"assessed":[189],"tolerability":[190,553],"measuring":[192],"discontinuation":[194],"owing":[195],"treatment-emergent":[197,377,439,456],"adverse":[198,378,415,440,457],"events":[199,379,416,441],"safety":[206,368],"population":[207,257,369],"(all":[208,258],"participants":[209,260,345,424,445,451,475],"who":[210,261],"received":[211,262],"\u22651":[212,263,278],"study":[216,266,295,306,310,469],"period).":[221],"Secondary":[222],"endpoints":[224],"related":[225,467],"clinical":[227,578],"50%":[232,479],"reduction":[233,480,512],"from":[234,243,513],"mean":[237,246,482,516,528],"monthly":[238,247,483,517],"change":[242],"4-6":[252],"modified":[255],"intention-to-treat":[256],"randomised":[259],"treatment,":[267],"an":[269],"evaluable":[270,279],"eDiary":[274,286],"data,":[275],"postbaseline":[280],"4-week":[281],"[1":[282],"month]":[283],"data":[287],"within":[288],"24":[289,557],"weeks":[290,558],"after":[291],"first":[292],"medication":[296],"[month":[297],"1":[298],"6],":[301],"regardless":[302],"whether":[304],"off":[309],"treatment).":[311],"registered":[314],"ClinicalTrials.gov":[316],"(NCT05748483)":[317],"EU":[319],"Clinical":[320],"Trials":[321],"Register":[322],"(2022-501172-25-00);":[323],"completed":[328],"ongoing.":[334],"FINDINGS:":[335],"Between":[336],"Oct":[337],"7,":[338],"2023,":[339],"April":[341],"28,":[342],"2025,":[343],"730":[344],"screened,":[347],"545":[348],"assigned,":[351],"540":[353],"(479":[354],"[89%]":[355],"female":[356],"61":[358],"[11%]":[359],"male,":[360],"517":[361],"[96%]":[362],"White)":[363],"included":[365],"(atogepant":[370],"n=273;":[371],"n=267).":[373],"Discontinuation":[374],"due":[375],"lower":[386],"group":[390,399,428,489,498,525,535],"(33":[391],"[12%]":[392],"273)":[394],"(79":[400],"[30%]":[401],"267;":[403],"relative":[404],"risk":[405],"[RR]":[406],"0\u00b74,":[407],"95%":[408,505],"CI":[409,506],"0\u00b73":[410],"0\u00b76;":[412],"p<0\u00b70001).":[413,544],"Treatment-related":[414],"reported":[418],"153":[420],"(56%)":[421],"273":[423],"208":[430],"(78%)":[431],"267":[433],"group.":[437],"Serious":[438],"occurred":[442],"six":[444],"three":[450],"topiramate.":[453,561],"One":[454],"serious":[455],"event":[458],"(anaphylactic":[459],"reaction":[460],"group)":[464],"considered":[466],"drug.":[470],"No":[471],"deaths":[472],"occurred.":[473],"More":[474],"experienced":[476],"(64%":[490],"[173":[491],"270])":[493],"(39%":[499],"[101":[500],"257],":[502],"RR":[503],"1\u00b76,":[504],"1\u00b74":[507],"2\u00b70,":[509],"p<0\u00b70001)":[510],"greater":[521],"(least":[526],"squares":[527],"-6\u00b73":[529],"[SE":[530],"0\u00b73])":[531],"than":[532],"(-4\u00b75":[536],"[0\u00b73];":[537],"difference":[539],"-1\u00b78":[540],"[-2\u00b75":[541],"-1\u00b70];":[543],"INTERPRETATION:":[545],"Atogepant":[546],"60":[547],"daily":[550],"showed":[551],"better":[552],"Although":[562],"both":[563],"are":[567],"established":[568],"effective":[570],"treatments,":[574],"their":[575,605],"usefulness":[576],"practice":[579],"hinges":[580],"patients'":[582],"ability":[583],"tolerate":[585],"treatment.":[586],"Our":[587],"findings":[588],"that":[593],"might":[594],"guide":[595],"clinicians":[596],"selecting":[598],"most":[600],"appropriate":[601],"therapy":[603],"patients.":[606],"FUNDING:":[607],"AbbVie.":[608]},"counts_by_year":[],"updated_date":"2026-07-25T05:54:39.514286","created_date":"2026-07-24T00:00:00"}